M&A Deal Summary |
|
|---|---|
| Date | 2020-08-19 |
| Target | Centauri |
| Sector | Information Technology |
| Buyer(s) | KBR |
| Sellers(s) | Arlington Capital Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 827M USD |
| Advisor(s) | Jefferies (Financial) Holland & Knight (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1901 |
| Sector | Engineering |
| Employees | 30,000 |
| Revenue | 7.0B USD (2023) |
KBR is an engineering, construction, and services company supporting the global hydrocarbons and international government services market segments. The company offers a portfolio of proprietary technology and consulting services; engineering, construction, procurement, and asset maintenance services; and base operational, logistics, life support, and asset management services, through its technology & consulting, engineering & construction, and government services business segments. KBR was founded in 1901 and is based in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 20 |
| Sector (Information Technology) | 4 of 5 |
| Type (Add-on Acquisition) | 10 of 13 |
| State (Virginia) | 1 of 1 |
| Country (United States) | 8 of 10 |
| Year (2020) | 1 of 1 |
| Size (of disclosed) | 1 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-08-08 |
RRT Global - Isomerization Technologies
St. Petersburg, Russia RRT Global - Isomerization Technologies produces a desirable feedstock for alkylation units and offers refiners a higher octane gasoline blendstock that is free from benzene, aromatics, oxygenates and olefins. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-13 |
Frazer-Nash Consultancy
Surrey, United Kingdom Frazer-Nash Consultancy provides a broad range of professional advisory services across the defense, energy, and critical infrastructure sectors primarily in the U.K. and Australia. With expertise in areas such as systems engineering, data science, cyber, and clean energy. Frazer-Nash Consultancy is based in Surrey, United Kingdom. |
Buy | $400M |
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 7.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Arlington Capital Partners is a middle-market private equity firm focused on buyouts and recapitalizations in targeted growth industries. Arlington targets US based companies valued between $50 and $500 million with strong potential for organic growth and possible consolidation opportunities. Sectors of interest include business services and outsourcing, aerospace/defense, federal and commercial IT, media, education and training, healthcare services, and manufacturing. Arlington Capital was formed in 1999 and is headquartered in Washington DC.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 37 |
| Sector (Information Technology) | 10 of 11 |
| Type (Add-on Acquisition) | 15 of 19 |
| State (Virginia) | 8 of 10 |
| Country (United States) | 30 of 35 |
| Year (2020) | 1 of 1 |
| Size (of disclosed) | 1 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-03 |
Qarbon Aerospace
Red Oak, Texas, United States Qarbon Aerospace is a provider of large, complex structural components and assemblies such as fuselages, wings, flight control surfaces, and engine nacelles. The Company operates nearly two million square feet of factory space across three facilities located in Red Oak, Texas, Milledgeville, Georgia, and Rayong, Thailand. Qarbon Aerospace has vertically integrated manufacturing capabilities from component fabrication through the large-scale assembly as well as proprietary thermoplastics technologies. The Company has longstanding relationships with blue-chip OEM customers and a diversified product portfolio across a variety of successful commercial, defense, and business jet platforms. Qarbon Aerospace is based in Red Oak, Texas. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-07 |
Everest Clinical Research
Markham, Ontario, Canada Everest Clinical Research is a contract research organization (“CRO”) providing a comprehensive suite of mission-critical clinical research services to the worldwide pharmaceutical, biotechnology, and medical device industries across Phase I-IV trials. Everest Clinical Research was founded in 2004 and is based in Markham, Ontario. |
Buy | - |
